Guanylate-binding protein 1 inhibits Hantaan virus infection by restricting virus entry

Hantaan virus (HTNV) Infection can cause hemorrhagic fever with renal syndrome (HFRS) in humans, and currently, there are no long-standing protective vaccines or specific antivirals available. Guanylate-binding protein 1 (GBP1) is an interferon-stimulated gene that defends against various pathogen infections. However, the function of GBP1 in HTNV Infection remains unknown. Here, we describe how GBP1 prevents HTNV Infection by obstructing virus entry. We found that HTNV Infection induced GBP1 expression and that overexpression of GBP1 inhibited HTNV Infection, while knockout of GBP1 had the opposite effect. Interestingly, GBP1 did not affect interferon (IFN) signaling during HTNV Infection. Instead, GBP1 prevented HTNV from entering cells through clathrin-mediated endocytosis (CME). We also discovered that GBP1 specifically interacted with actin but not Dynamin 2 (DNM2) and made it difficult for DNM2 to be recruited by actin, which may account for the suppression of CME during HTNV Infection. These findings establish an Antiviral role for GBP1 in inhibiting HTNV Infection and help us better understand how GBP1 regulates HTNV entry and could potentially aid in developing treatments for this virus.

Hantaan virus (HTNV); clathrin‐mediated endocytosis (CME); guanylate‐binding protein 1 (GBP1); interferon stimulated genes (ISGs).